Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 78 results

Discount Pharmacies May Save Patients Significant Money on Androgenetic Alopecia Medications Compared to Both Traditional Pharmacies and Direct-to-Consumer Companies

research Discount Pharmacies May Save Patients Significant Money on Androgenetic Alopecia Medications Compared to Both Traditional Pharmacies and Direct-to-Consumer Companies

March 2025 in “Journal of the American Academy of Dermatology”

Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.

Evaluating Safety and Ethical Implications of Androgenetic Alopecia Treatments: A Comparison of Direct-to-Consumer Platforms and Dermatologist Visits

research Evaluating Safety and Ethical Implications of Androgenetic Alopecia Treatments: A Comparison of Direct-to-Consumer Platforms and Dermatologist Visits

December 2024 in “Journal of the American Academy of Dermatology”

Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.

research Direct-To-Consumer Teledermatology Growth: A Review And Outlook For The Future

7 citations , April 2022 in “Cutis”

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

research The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy Issues

244 citations , September 2008 in “Annual Review of Genomics and Human Genetics”

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

research Accessibility of Direct-to-Consumer Teledermatology to Underserved Populations

4 citations , March 2022 in “Journal of The American Academy of Dermatology”

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

View more "dtc" in research →

Community Join

2 / 2 results

community Today was Last update on pp405

in Research/Science 108 upvotes 8 months ago

A new hair loss treatment, PP405, is moving from phase 2A to 2B in clinical trials, sparking discussions about its potential to regrow dormant hairs and its impact on existing treatments like Minoxidil and finasteride. Some users express skepticism, while others are hopeful about its future effectiveness.

community 7 Months. 1mg fin. min once at night. Weekly 1.5mm Microneedling.

in Progress Pictures 190 upvotes 1 year ago

The conversation is about a user's progress in treating hair loss using 1mg finasteride, topical minoxidil once at night, and weekly 1.5mm microneedling. The user reports significant improvement and no side effects, while others discuss their experiences and offer advice on similar treatments.